Friday, December 5, 2025
Search

BlackRock Floating Rate Income Trust, AbbVie, Another 2 Companies Have A High Estimated Dividend Yield

Via News Editorial Team

October 13, 2022

BlackRock Floating Rate Income Trust, AbbVie, Another 2 Companies Have A High Estimated Dividend Yield

(VIANEWS) - BlackRock Floating Rate Income Trust (BGT), AbbVie (ABBV), James Hardie Industries plc (JHX) have the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 BlackRock Floating Rate Income Trust (BGT) 10.80 0% 7.14% 2022-09-28 09:06:08
2 AbbVie (ABBV) 140.25 -0.89% 3.93% 2022-10-12 14:55:11
3 James Hardie Industries plc (JHX) 20.09 1.46% 3.56% 2022-09-30 13:15:07
4 Lockheed Martin Corporation (LMT) 398.05 -3.16% 2.71% 2022-10-12 14:55:10

Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. BlackRock Floating Rate Income Trust (BGT) - Dividend Yield: 7.14%

BlackRock Floating Rate Income Trust's last close was $10.80, 26.73% under its 52-week high of $14.74.

BlackRock Floating Rate Income Trust, a closed-ended fixed income mutual fund that was launched in 2012 by BlackRoack Inc. BlackRock Advisors, LLC, and BlackRock Financial Management, Inc. co-manage the fund. The fund invests in fixed income markets around the world, with a focus on the United States. It invests in bonds issued by companies that operate across diverse sectors. The fund invests in corporate bonds whose average duration will not exceed 1.5 years. Formerly known as BlackRock GlobalFloating Rate Income trust, the fund is now called BlackRock Global Floating rate income trust. BlackRock Floating Rate Income Trust, which was established on August 30, 2004, is based in the United States.

Earnings Per Share

As for profitability, BlackRock Floating Rate Income Trust has a trailing twelve months EPS of $0.82.

PE Ratio

BlackRock Floating Rate Income Trust has a trailing twelve months price to earnings ratio of 13.17. Meaning, the purchaser of the share is investing $13.17 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -5.63%.

More news about BlackRock Floating Rate Income Trust.

2. AbbVie (ABBV) - Dividend Yield: 3.93%

AbbVie's last close was $139.98, 20.43% under its 52-week high of $175.91.

AbbVie Inc. develops, produces, and markets pharmaceuticals worldwide. HUMIRA is an injectable therapy for autoimmune Behcet's disease; SKYRIZI for moderate to severe plaque psoriasis; RINVOQ to treat mild to moderately severe active rheumatoidarthritis in adults; IMBRUVICA for adults with chronic lymphocyticleukemia (CLL) or small lymphocytic lioma (SLL); and VENCLEXTA to treat chronic HCV genotype 1-6 patients. The company also offers CREON, an exocrine-pancreatic enzyme therapy to treat hypothyroidism. Linzess/Constella is used for irritable bowel syndrome and chronic idiopathic constipation. Lupron can be used for palliative care of advanced prostate cancer and endometriosis. Botox Therapeutic will be used for patients suffering from uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. collaborates with Dragonfly Therapeutics, Inc. It was founded in 2012, and its headquarters are in North Chicago (Illinois).

Earnings Per Share

As for profitability, AbbVie has a trailing twelve months EPS of $2.91.

PE Ratio

AbbVie has a trailing twelve months price to earnings ratio of 48.15. Meaning, the purchaser of the share is investing $48.15 for every dollar of annual earnings.

Yearly Top and Bottom Value

AbbVie's stock is valued at $140.25 at 20:16 EST, way below its 52-week high of $175.91 and way higher than its 52-week low of $106.86.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 57.35B for the twelve trailing months.

Moving Average

AbbVie's worth is below its 50-day moving average of $140.29 and under its 200-day moving average of $146.54.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

AbbVie's stock is considered to be oversold (<=20).

More news about AbbVie.

3. James Hardie Industries plc (JHX) - Dividend Yield: 3.56%

James Hardie Industries plc's last close was $19.80, 52.69% under its 52-week high of $41.85.

James Hardie Industries plc and its affiliates manufacture and sell fiber cement siding. These products are mainly sold in the United States of America, Canada, Australia and New Zealand. The company operates in North America Fiber Cement and Asia Pacific Fiber Cement segments. It also offers Europe Building Products and Research and Development. It offers interior and exterior fiber cement linings and accessories, as well as fiber cement building materials. These include external siding, floor, ceilings and floors. The company also offers planks that can be used as external siding, flat panels for internal and exterior wall linings and floor underlays. It also has cement-bonded boards and fiber gypsum boards to use for interior purposes, including dry lining walls and walls in timber frames buildings. Its products can be found in a variety of markets, including new residential construction and manufactured housing. The company markets fiber cement products under several brands such as HardiePlank and HardieTrim; Hardieflex and HardieFire; HardieSmart Boundary; Hardieflex and HardieEdge; HardieFire and HardieFire; Hardieflex and HardieEdge; HardieFire and HardieFire; Hardieflex and HardieEdges; Stria and Stria; Fermacell; Fermacell; Fermacell; Fermacell and Fermacell and Fermacell; Ritek and Ritek; Ritek and Ritek; Ritek and Ritek; Ritek and Ritek; and Fermacell and Fermacell and Fermacell and Fermacell and Fermacell and Fermacell and Fermatech, Ritek and Ritek; and Fermacell and Fermacell and Fermacell and Scyon and Ritek and Fermacell and Fermacell and Fermacell It was established in Dublin, Ireland in 1888.

Earnings Per Share

As for profitability, James Hardie Industries plc has a trailing twelve months EPS of $1.13.

PE Ratio

James Hardie Industries plc has a trailing twelve months price to earnings ratio of 17.78. Meaning, the purchaser of the share is investing $17.78 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 39.83%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 25, 2022, the estimated forward annual dividend rate is 0.7 and the estimated forward annual dividend yield is 3.56%.

Volume

Today's last reported volume for James Hardie Industries plc is 61541 which is 33.49% below its average volume of 92530.

Moving Average

James Hardie Industries plc's value is way under its 50-day moving average of $23.38 and way under its 200-day moving average of $28.68.

Earnings Before Interest, Taxes, Depreciation, and Amortization

James Hardie Industries plc's EBITDA is 40.39.

More news about James Hardie Industries plc.

4. Lockheed Martin Corporation (LMT) - Dividend Yield: 2.71%

Lockheed Martin Corporation's last close was $411.06, 14.36% below its 52-week high of $479.99.

Lockheed Martin Corporation is an aerospace and security company that engages in research, design and development of products and technologies. The company operates in four areas: Aeronautics and Missiles and Fire Control; Rotary and Mission System, and Space. Aeronautics offers unmanned aircraft and combat- and air mobility planes, as well as related technologies. Missiles and Fire Control provides missile and air defense systems, tactical missiles and ground-to-ground precision strikes weapon systems, logistics, fire control systems, mission operations support and engineering support as well as integration services. It also offers energy management and energy management options. Rotary and Mission System offers military and civilian helicopters as well as surface and ground-based missile defense systems. It also provides radar systems and sea- and air-based missions and combat systems. Command and control mission solutions and cyber solutions are available. Space offers space transport systems, satellites, strategic, advanced strike and defense missile systems, as well as classified services and systems to support national security system systems. The segment provides network-enabled status awareness, integrates ground and space-based systems, to assist customers in gathering, analyzing, and securely distributing critical intelligence data. This segment serves the U.S. government and foreign military sales through the U.S. Lockheed Martin Corporation was established in 1912, and its headquarters is in Bethesda in Maryland.

Earnings Per Share

As for profitability, Lockheed Martin Corporation has a trailing twelve months EPS of $24.78.

PE Ratio

Lockheed Martin Corporation has a trailing twelve months price to earnings ratio of 16.06. Meaning, the purchaser of the share is investing $16.06 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 52.39%.

Moving Average

Lockheed Martin Corporation's worth is below its 50-day moving average of $419.98 and under its 200-day moving average of $416.25.

Revenue Growth

Year-on-year quarterly revenue growth declined by 9.3%, now sitting on 64.17B for the twelve trailing months.

Sales Growth

Lockheed Martin Corporation's sales growth is 4.3% for the present quarter and 2.4% for the next.

More news about Lockheed Martin Corporation.